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Australia, Adelaide, AustraliaA B S T R A C TObjectives: To describe the use of a novel approach in health
valuation of a discrete choice experiment (DCE) including a cost
attribute to value a recently developed classiﬁcation system for
measuring the quality-of-life impact (both health and treatment
experience) of self-management for diabetes.Methods: A large online
survey was conducted using DCE with cost on UK respondents from
the general population (n ¼ 1497) and individuals with diabetes
(n ¼ 405). The data were modeled using a conditional logit model
with robust standard errors. The marginal rate of substitution was
used to generate willingness-to-pay (WTP) estimates for every state
deﬁned by the classiﬁcation system. Robustness of results was
assessed by including interaction effects for household income.
Results: There were some logical inconsistencies and insigniﬁcant
coefﬁcients for the milder levels of some attributes. There were some
differences in the rank ordering of different attributes for the general
population and diabetic patients. The WTP to avoid the most severeee front matter Copyright & 2017, International S
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ndence to: Donna Rowen, School of Health and Re
4DA, UK.state was £1118.53 per month for the general population and £2356.02
per month for the diabetic patient population. The results were largely
robust. Conclusions: Health and self-management can be valued in a
single classiﬁcation system using DCE with cost. The marginal rate of
substitution for key attributes can be used to inform cost-beneﬁt
analysis of self-management interventions in diabetes using results
from clinical studies in which this new classiﬁcation system has been
applied. The method shows promise, but found large WTP estimates
exceeding the cost levels used in the survey.
Keywords: cost, diabetes, discrete choice experiment, preference-
based measures.
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Discrete choice experiment (DCE) methods are increasingly being
applied as a means to value the beneﬁts of health care inter-
ventions. DCEs have usually been used to value the process of
health care (either in isolation of or in combination with health
outcomes) using bespoke or study-speciﬁc attributes developed
for individual studies [1]. Recent DCE applications in diabetes
include, for example, an investigation of patient preferences for
insulin therapy and clinical outcomes in type 2 diabetes [2].
Recent work has extended the use of DCE to valuing classiﬁcation
systems for measuring health-related quality of life (HRQOL)
such as the ﬁve-level EuroQol ﬁve-dimensional questionnaire
(EQ-5D-5L) [3] and the six-dimensional health state short form
(SF-6D) [4,5] on the 0 to 1 quality-adjusted life-year (QALY) scaleby adding an additional attribute for duration. This approach has
been referred to as the DCETTO (TTO, time trade-off) approach in
the literature [6–11]. These health state utility values can then be
used to estimate QALYs for use in cost-utility analysis and for
submission to regulatory agencies such as the National Institute
of Health and Care Excellence in the United Kingdom [12] or the
Pharmaceutical Beneﬁts Advisory Committee in Australia [13].
An alternative to cost-utility analysis is cost-beneﬁt analysis
(CBA), in which the beneﬁts of interventions are represented by
monetary values. This approach has been used to capture the
beneﬁts of interventions beyond the health outcomes achieved
including beneﬁts gained from the process of care delivery.
Monetary values of the beneﬁts of interventions are often
measured directly by asking respondents how much they would
be willing to pay for one intervention over another (e.g., [14]). DCEociety for Pharmacoeconomics and Outcomes Research (ISPOR).
BY-NC-ND license
lated Research, University of Shefﬁeld, Regent Court, 30 Regent
V A L U E I N H E A L T H ] ( 2 0 1 7 ) ] ] ] – ] ] ]2methods may also be applied to obtain willingness-to-pay (WTP)
estimates indirectly [15–17] by including cost as an additional
attribute in the DCE. As mentioned previously, this approach has
been applied recently in diabetes (e.g., in the study by Feher et al. [2]).
Nevertheless, to our knowledge, to date this methodology has not
been used to value a pre-existing classiﬁcation system. Applica-
tion of a DCE approach in this context provides an analogous way
of valuing health to DCETTO used with the EQ-5D and the SF-6D,
but provides monetary estimates of the WTP to avoid a health
state that can potentially be used to inform CBA.
Diabetes costs across the globe are rising because of the
increased prevalence of the disease and the increased complexity
of its treatment. For example, in the United Kingdom, £936.7
million was spent on prescriptions for diabetes in 2015 [18], and
the total cost of diabetes in the United Kingdom is estimated to
be £23.7 billion [19]. Structured education in diabetes is one of
nine key care process checks recommended by the National
Institute of Health and Care Excellence [20]. It beneﬁts patients
by giving them the conﬁdence and skills to self-manage their
condition, but of those newly diagnosed, less than 6% have been
recorded as attending such a course. Evaluating the true mone-
tary value of interventions designed to improve self-manage-
ment is urgently needed. Self-management of diabetes varies
from one individual to another, and similarly the impact of self-
management upon an individual is also very personal.
Currently, quality of life is linked to QALYs on the basis of
questionnaires that are not diabetes-speciﬁc (e.g., the EQ-5D or
the SF-12), and so the intended improvement in self-manage-
ment skills of an intervention cannot be evaluated in economic
terms. Likewise, measures that are diabetes-speciﬁc (e.g., Prob-
lem Areas in Diabetes [21]) are not linked to QALYs. The
classiﬁcation system used in this study was developed to provide
a formal and consistent way to take account of self-management
across different interventions, because existing measures do not
consider the direct impact of different self-management regimes
on patients’ quality of life from their own perspective [22].
Without the use of a single widely applicable classiﬁcation
system, the change in processes is often measured using study-
speciﬁc descriptions or vignettes, rather than assessing the
impact on quality of life through the use of patient-completed
questionnaires in clinical studies.
This article describes the use of DCE including a cost attribute
to value a classiﬁcation system measuring the quality-of-life
impact of self-management for diabetes. The article presents a
DCE survey with a cost attribute conducted in general population
and diabetic patient samples as well as the results of regression
analyses to model the DCE data to provide monetary values of
the WTP to avoid each state deﬁned by the classiﬁcation system
for both general population and diabetic patient samples. We
then discuss the results in terms of the implications for valuing
this and other classiﬁcation systems using this method.Methods
Classiﬁcation System
The Health and Self-Management in Diabetes classiﬁcation sys-
tem was developed to capture the impact of self-management on
quality of life in diabetes (see Fig. 1). Four of the dimensions
(mood, hypoglycemic attacks, vitality, and social limitations)
represent HRQOL and the remaining four dimensions (control,
hassle, stress, and support) represent self-management. The
dimensions of HRQOL are taken from the Diabetes Health
Proﬁle-Five Dimension [23], a diabetes preference-based measure
developed from the Diabetes Health Proﬁle [24,25] and the short
form 36 health survey (the vitality item) [26]. The development ofthe classiﬁcation system is reported in detail elsewhere [22] and
research is ongoing to determine the psychometric properties of
the measure and its performance relative to the EQ-5D-5L.
Valuation Technique
DCE tasks present two or more proﬁles, in which each proﬁle
consists of attribute levels selected from a classiﬁcation system
and respondents are asked to indicate their preferred proﬁle. DCE
was selected in this study because it enables WTP values to be
generated for every state deﬁned by the classiﬁcation system
through the inclusion of a cost attribute, and the technique is
amenable to online data collection [1].
Selecting the Levels of the Cost Attribute
Limited guidance is provided in the DCE literature about how to
choose levels for a cost attribute, and many published studies are
either extremely brief in their details of how they determined the
levels for the cost attribute or do not report details at all.
Nevertheless, the levels should accurately capture the range of
preferences for most of the respondents; otherwise, their inclu-
sion will not add any useful information. It is important to ensure
the levels are not too high or too low for the treatment or
condition being valued, because otherwise cost would be either
prohibitive or irrelevant [15]. It has been argued that the range for
the cost attribute levels should incorporate values that are higher
than the market price, because this may not be the maximum
amount that people are willing to pay [16]. Typically, cost levels
used in the literature reﬂect a range around mean cost that
includes either a low cost or zero cost. In terms of wording the
cost attribute, previous DCE experiments with a cost attribute in
diabetes have used “personal cost to you each month” [27],
“payment per month out of pocket,” [2] and “cost of diabetes
medicines each month” [28].
To empirically inform the selection of the levels of the cost
attribute, an online binary choice survey of 400 members of the
general population was conducted to assess people’s WTP for
hypothetical self-management and HRQOL states (recruitment
followed the same process for the main general population
survey reported later). Respondents completed experimental
binary choice questions, where each question was a choice
between a poor state with zero cost or a good state with nonzero
cost that was randomly varied across different questions using
various levels (across different survey versions the levels used
were £10, £25, £50, £75, £100, £150, £200, £300, £400, and £600).
The proportions of respondents choosing the better state with
nonzero cost were compared to determine how the different
costs impacted on choice.
Four levels of the cost attribute were selected, in common
with the four severity levels of all other attributes. In the
literature of DCE involving a cost attribute to determine WTP,
the severity levels are not usually equal but increase exponen-
tially (e.g., 2, 4, 8, 16), and this approach was used here to inform
the selection of levels. The lowest level of £10 was selected
because about a quarter of the respondents being asked the
question were not willing to pay £10 to improve their health. The
highest level of £600 was selected as the upper end because about
one-third of the respondents were willing to pay £600 to improve
their health. Levels of £75 and £200 were selected to represent the
intermediate cost levels to ensure good coverage.
Selecting Proﬁles
Eight attributes from the classiﬁcation system plus four cost levels
resulted in 262,144 proﬁles, and many millions of possible pairs.
Therefore, a subset of proﬁles was selected using D-optimal
methods in Ngene software, distributed by ChoiceMetrics [29] to
Dimension Level Wording
Mood 1 You never find yourself losing your temper over small things
2 You sometimes find yourself losing your temper over small 
things 
3 You usually find yourself losing your temper over small 
things
4 You always find yourself losing your temper over small 
things
Hypoglycemic attacks 1 You never worry about going hypo
2 You sometimes worry about going hypo
3 You usually worry about going hypo
4 You always worry about going hypo
Vitality 1 You are never tired 
2 You are sometimes tired 
3 You are usually tired 
4 You are always tired 
Social Limitations 1 Your days are never tied to meal times
2 Your days are sometimes tied to meal times
3 Your days are usually tied to meal times
4 Your days are always tied to meal times
Control 1 You feel you have a lot of control of your diabetes
2 You feel you have some control of your diabetes
3 You feel you have little control of your diabetes
4 You feel you have no control of your diabetes
Hassle 1 You find your life with diabetes is never a hassle
2 You find your life with diabetes is sometimes a hassle
3 You find your life with diabetes is often a hassle
4 You find your life with diabetes is always a hassle
Stress 1 You find your life with diabetes is never stressful
2 You find your life with diabetes is sometimes stressful
3 You find your life with diabetes is often stressful
4 You find your life with diabetes is always stressful
Support (All support you 
have; from family, friends, 
and health care 
professionals)
1 You feel totally supported with your diabetes
2 You feel you have a lot of support with your diabetes
3 You feel you have a little support with your diabetes
4 You feel you have no support with your diabetes
Fig. 1 – Health and self-management in diabetes classiﬁcation system.
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prespeciﬁed regression model with precision. The design selected
120 choice sets across 10 survey versions (12 per survey) and was
piloted (50 respondents) to generate priors for each attribute level of
each dimension. These priors were then used to generate the
design (i.e., select 120 choice sets) for the main study. The rationale
for this was to improve the efﬁciency of the design with informa-
tion regarding the magnitude of the parameter values.Respondents
Presently, there is no consensus in the literature about whether
values should be obtained from the general population or from a
patient sample [30]. This article does not propose to review this
debate, but given the diversity of viewpoints, values have been
collected from both general population and individuals with
diabetes.General population sample
Respondents were recruited by a market research agency using
an existing online panel. Respondents were selected to obtain a
representative sample of the UK population in terms of age and
sex. They were rewarded for their participation with a nominal
amount of vouchers that could be accumulated and exchanged
for goods.Patient sample
Diabetic patients were recruited in various ways to ensure a good
coverage across different groups in terms of severity, background,
and setting:1. Posters in clinics and invitation letters posted with the usual
clinic appointment letter to patients at Shefﬁeld Teaching
Hospitals;
V A L U E I N H E A L T H ] ( 2 0 1 7 ) ] ] ] – ] ] ]42. Invitation letters posted to members of the Shefﬁeld Diabetes
Research Database who have previously provided consented
to receive information about diabetes research projects;3. Diabetes UK and DAFNE Online advertised a link to the online
survey;4. Twitter and Facebook posts to diabetes charities, organiza-
tions, and the University of Shefﬁeld staff and students and
using a social media marketing company.
All patient respondents were offered optional entry into a
prize draw for £50 shopping vouchers per 50 respondents.
The DCE Survey
Respondents were presented with the project information sheet
and consented. They then completed sociodemographic and
health questions asking about sex, age, education level, annual
household income, and whether they have diabetes. After this,
respondents were provided with information about what it is like
to live with diabetes and were asked to complete the Health and
Self-Management in Diabetes classiﬁcation system for them-
selves if they had diabetes or imagine someone with diabetes
to familiarize themselves with the classiﬁcation system.
Respondents were then given an introduction to the DCE ques-
tions (shown in Supplemental Materials found at http://dx.doi.
org/10.1016/j.jval.2017.06.016). Respondents then answered 1
practice DCE question plus 12 DCE questions, where respondents
chose between health description A and health description B, an
example question of which is shown in Figure 2. Respondents
were told to imagine that these health descriptions would last for
10 years and then they would die. Attributes that differed across
the two health descriptions were highlighted in yellow. Finally,
patients were also asked about their self-management of
diabetes.
Piloting
The draft survey instrument was shown to a general patient and
public involvement panel for comments and piloted with 50
members of the general population to inform the ﬁnal survey
design.
Analysis
Sociodemographic and self-reported health characteristics were
analyzed and categorized.
The DCE data were modeled using the following model
speciﬁcation:
μij¼αiþβ1cijþβ′2xijþεij, ð1ÞHealth description A
You always find yourself losing your 
temper over small things
You sometimes worry about going hy
You are never tired 
Your days are never tied to meal time
You feel you have some control of yo
diabetes
You find your life with diabetes is nev
hassle
You find your life with diabetes is nev
stressful
You feel totally supported with your 
diabetes
Which do you 
prefer?
The monthly cost of treatment to you
£10
Fig. 2 – Example DCE question. DCEwhere cij represents cost, β1 is the coefﬁcient for costs, and β′2
represents the coefﬁcients for the 24 nonreference attribute levels of
the classiﬁcation system. This model produces unanchored values
for scenarios or combinations of attribute levels. The monetary value
(WTP) of each level of each attribute is estimated by dividing the
coefﬁcient attached to the relevant attribute level by the coefﬁcient
attached to the cost attribute (after previous checking for the linearity
of the cost attribute) to generate the marginal rate of sub-
stitution,
β2ij
β1
β2ij
β1
. This enables the monetary value of self-management
alone, or the combined monetary value of HRQOL and self-manage-
ment, to be estimated. Models were estimated separately for the
general population and the diabetic patient samples. Models were
estimated using the conditional logit model with robust standard
errors, and conﬁdence intervals and standard errors of the WTP
estimates were determined using the delta method. Model perform-
ance was examined using sign, signiﬁcance, and logical consistency
of coefﬁcients, log likelihood, and pseudo-R2. The models assumed
that cost was linear and a continuous variable. This was examined
by modeling cost as a categorical variable and plotting the cost
coefﬁcients [31].
Robustness
Regressions were re-estimated excluding all responses to the DCE
questions that were achieved within an implausibly short time
period because it is likely that such quick responses indicate that
these respondents are less likely to have read, understood, and
considered the proﬁles. Regression models were also estimated to
determine whether sociodemographic characteristics impacted
on the results, including main effects plus interaction effects (one
at a time) for the sociodemographic characteristics of age, sex,
low income, high income, EQ-5D score, and whether the respond-
ent has diabetes.Results
The Sample
The characteristics of the general population and diabetic patient
samples compared with those of the UK general population are
presented in Table 1. The general population sample has a
similar proportion of males and similar employment status to
the UK general population, but has a lower proportion of
respondents older than 65 years. The diabetic patient samples
have a lower proportion of males, respondents with a degree
qualiﬁcation, employed respondents, and respondents in the
higher income category; a larger proportion of respondents older
than 65 years; and a lower EQ-5D-5L score (scored using theHealth description B
You never find yourself losing your 
temper over small things
po You never worry about going hypo
You are always tired 
s Your days are usually tied to meal times
ur You feel you have no control of your 
diabetes
er a You find your life with diabetes is 
always a hassle
er You find your life with diabetes is 
always stressful
You feel you have a little support with 
your diabetes
 is The monthly cost of treatment to you is 
£75
, discrete choice experiment.
Table 1 – Samples of respondents to the DCE survey, by population, in comparison with the UK general
population.
Characteristic General population
(n ¼ 1,497)
Diabetic population
(n ¼ 405)
UK general population†
Sex, male 48.6% 41.5% 49.1%
Age (y)
18–44 47.0% 40.0% 46.6%*
45–64 39.7% 35.3% 32.5%
465 13.3% 24.7% 20.9%
Has a degree or equivalent professional qualiﬁcation 52.9% 45.9%
Main activity
Employed 60.5% 45.4% 61.7%
Retired 18.0% 29.9% 13.9%
Housework 6.7% 5.7% 4.3%
Student 4.5% 3.7% 9.3%
Seeking work 1.3% 1.5%
Unemployed 3.1% 3.0% 4.4%
Long-term sick 4.8% 9.4% 4.3%
Other 1.1% 1.5% 2.2%
EQ-5D-5L, mean ± SD 0.79 ± 0.25 0.70 ± 0.27
Have diabetes 13.2% 100.0%
Have type 1 diabetes 2.5% 47.7%
Have type 2 diabetes 10.6% 52.3%
Annual household income (£)
Up to 5,199 2.8% 4.7%
5,200–10,399 6.1% 6.4%
15,400–15,599 8.6% 10.9%
15,600–20,799 8.5% 11.4%
20,800–25,599 10.6% 11.4%
26,000–31,199 10.2% 8.1%
31,200–36,399 9.6% 5.9%
36,400–51,999 15.5% 13.6%
452,000 18.5% 11.1%
Prefer not to say 9.6% 16.5%
DCE, discrete choice experiment; EQ-5D-5L, ﬁve-level EuroQol ﬁve-dimensional questionnaire.
⁎ Age distribution is here reported as the percentage of all adults aged 18 y and older.
† Statistics for England in the Census 2011. The census includes persons aged 16 y and older, whereas this study surveys only persons
aged 18 y and older.
V A L U E I N H E A L T H ] ( 2 0 1 7 ) ] ] ] – ] ] ] 5cross-walk from EQ-5D-5L to EQ-5D [32]). For a single DCE task
level, 37.1% of responses were completed within 10 seconds,
60.2% of responses were completed within 20 seconds, 94.1% of
responses were completed within 1 minute, and 99.1% of
responses were completed within 3 minutes.Regression Analysis
Regression results for the conditional logit model with robust
standard errors and the WTP values generated using the mar-
ginal rate of substitution are presented in Table 2. The speciﬁed
model is acceptable for both the general population and the
patient population using log likelihood and pseudo-R2. The WTP
values reﬂect the amount that respondents would be willing to
pay each month in pound sterling (£) to avoid decrement in the
HRQOL or the self-management attributes.
The cost coefﬁcient has the expected negative coefﬁcient,
showing that individuals are willing to pay to avoid decrements
in health or self-management outcomes. Previous analyses (not
reported) indicated that it was appropriate to assume cost was
linear and continuous, using a plot for each sample of the cost
levels and coefﬁcients estimated using a model in which cost was
included as a categorical variable.The estimated coefﬁcients of the HRQOL and the self-manage-
ment attributes are all negative and logically consistent, with the
exception of level 2 coefﬁcients for mood, vitality, and support,
although only the vitality level 2 coefﬁcient is approaching
signiﬁcance (at the 10% level). Out of a possible 25 coefﬁcients,
21 and 17 are statistically signiﬁcant in the models in the general
population and the diabetic patient population, respectively. All
level 3 and level 4 coefﬁcients are negative and signiﬁcant with
the exception of the level 3 coefﬁcient for vitality in the model
estimated for the diabetic patient population.
Table 3 presents the rank ordering of the level 4 coefﬁcients
for the general population and the diabetic patient samples,
which indicate the ordering of which attributes have the largest
impact on WTP at the most severe level. There are noticeable
differences, particularly for vitality and mood.
Figure 3 shows the relative size of the WTP values for the
general population and diabetic patient samples and shows the
relative importance of each of the attributes. The size of the WTP
values is similar to those of the HRQOL and the self-management
attributes, implying that self-management and HRQOL are
equally important. In general, the coefﬁcients of the patient
sample tend to be larger than those of the general population
sample for more severe levels of each attribute, but smaller
for the least severe level of each attribute. This suggests that
Table 2 – Regression analysis of DCE survey responses, by population, reporting unanchored and WTP
estimates.
Variable General population
unanchored estimates
(n ¼ 1497)
Diabetic population
unanchored estimates
(n ¼ 405)
General population
WTP estimates (£)
Diabetic population
WTP estimates (£)
Mood L2 0.0414 0.0033 16.52 2.79
Mood L3 −0.1226* −0.1094† −48.91* −93.31†
Mood L4 −0.2713* −0.3847* −108.25* −328.29*
Hypoglycemia L2 −0.0413 −0.0605 −16.49 −51.60
Hypoglycemia L3 −0.1814* −0.1426‡ −72.37* −121.71‡
Hypoglycemia L4 −0.2415* −0.2807* −96.38* −239.53*
Vitality L2 0.0581† 0.1075† 23.18† 91.71†
Vitality L3 −0.3036* −0.1016 −121.14* −86.68
Vitality L4 −0.5918* −0.2770* −236.17* −236.37*
Social limitations L2 −0.0205 −0.0153 −8.17 −13.06
Social limitations L3 −0.0977* −0.1585* −38.97* −135.23*
Social limitations L4 −0.1707* −0.2612* −68.12* −222.91*
Control L2 −0.1427* −0.0236 −56.94* −20.10
Control L3 −0.3010* −0.3372* −120.12* −287.72*
Control L4 −0.4441* −0.5343* −177.22* −455.88*
Hassle L2 −0.0971* −0.0649 −38.73* −55.35
Hassle L3 −0.2328* −0.2138* −92.89* −182.46*
Hassle L4 −0.4134* −0.3563* −164.95* −304.05*
Stress L2 −0.1543* −0.0601 −61.56* −51.29
Stress L3 −0.2188* −0.1465* −87.30* −125.03*
Stress L4 −0.3715* −0.3230* −148.25* −275.61*
Support L2 0.0506 0.0385 20.20 32.88
Support L3 −0.1266* −0.1859* −50.50* −158.61*
Support L4 −0.2987* −0.3438* −119.19* −293.38*
Cost −0.0025* −0.0012*
Note. Pseudo-R2 ¼ 0.160 for general population model; pseudo-R2 ¼ 0.101 for diabetic population model. Log likelihood ¼ −10458.4 for general
population model; log likelihood ¼ −3027.3 for diabetic population model.
DCE, discrete choice experiment; WTP, willingness to pay.
⁎ P o 0.01.
† P o 0.1.
‡ P o 0.05.
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willing to pay more to avoid severe health states in comparison
with the general population. For example, the WTP to avoid the
mild state of state 22222222 is £121.99 per month for the general
population and £64.02 per month for the diabetic patient pop-
ulation. In contrast, the WTP to avoid the most severe state of
44444444 is £1118.53 per month for the general population and
£2356.02 per month for the diabetic patient population.Table 3 – Absolute size ranking of level 4 WTP estimates
General population
Variable WTP estimate (£)
Vitality L4 −236.17
Control L4 −177.22
Hassle L4 −164.95
Stress L4 −148.25
Support L4 −119.19
Mood L4 −108.25
Hypoglycemia L4 −96.38
Social limitations L4 −68.12
WTP, willingness to pay.Robustness
Robustness analyses excluded all responses for a given DCE task
that were answered in less than 5 seconds (19% and 5% of
responses for general population and patients, respectively) and
in less than 10 seconds, respectively (40% and 16% of responses
for general population and patients, respectively), resulting in
larger WTP values at levels 3 and 4. This suggests that the, by population.
Diabetic population
Variable WTP estimate (£)
Control L4 −455.88
Mood L4 −328.29
Hassle L4 −304.05
Support L4 −293.38
Stress L4 −275.61
Hypoglycemia L4 −239.53
Vitality L4 −236.37
Social limitations L4 −222.91
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Fig. 3 – Anchored coefﬁcients for the general population and
diabetic patients.
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understood or engaged with the task will increase the size of the
WTP estimates. Regression models including main effects plus
interaction effects (one at a time) for the sociodemographic
characteristics of age, sex, low income, high income, EQ-5D score,
and whether the respondent has diabetes found no distinguish-
able pattern in terms of which coefﬁcients were signiﬁcant. This
was surprising for the income variables, given that it was
anticipated that WTP may increase as annual household income
increases.Discussion
This article describes the use of DCE including a cost attribute to
value a classiﬁcation system describing the impact of health and
self-management of diabetes on quality of life. The classiﬁcation
system is distinct in that it provides a formal and consistent way
to take account of self-management across different interven-
tions and one that is not intervention-speciﬁc. Nevertheless, to
use this information to inform health technology assessment, a
means of weighting the severity levels of each attribute to
produce a single score is required. This article describes a novel
application of the technique of DCE involving a cost attribute to
enable the valuation of a standardized classiﬁcation system to
provide WTP values for every state deﬁned by the classiﬁcation
system. The article also provides a comparison of general
population and diabetic population WTP values.
In the regression analysis, the WTP values for the HRQOL and
the self-management attributes are of similar magnitude, sug-
gesting that HRQOL and self-management have a similar relative
impact in terms of their utility decrement or amount respondents
are willing to pay to avoid more severe levels of the attribute.
This has important implications for policy, because it suggests
that the impact of changes in self-management on the lives of
people with diabetes can be as important as any HRQOL improve-
ment resulting from the change.
The largest difference in the rank ordering of the level 4
coefﬁcients between the general population and the patient
samples is the ranking of the vitality attribute, which is ranked
the most important for the general population, whereas it is
ranked the second least important for the patient population.
This is interesting given that it is the attribute in the classiﬁca-
tion system derived from the generic short form 36 health survey,
whereas the other items were all derived either from a diabetes-
speciﬁc measure or from interviews with people with diabetes.
Although this suggests that the general population may place a
higher relative value on reductions in vitality than the diabetic
patient population, the absolute value is similar for both samples.In addition, the mood attribute is ranked the second most
important for the diabetic population but the third least impor-
tant for the general population. Nevertheless, both the hypogly-
cemic attack and the social limitations attributes are ranked
among the least important for both populations.
The WTP per month to avoid state 44444444 is £1118.53 for the
general population and £2356.02 for the diabetic patient popula-
tion. This is signiﬁcantly larger than the largest cost level
included in the survey of £600 per month. An indication of how
large these values are relative to annual household income can
be calculated. Approximately 23.9% of the general population
sample has an annual household income less than £20,800, and
for these respondents this would represent at least 64.5% of their
income (£13,422.36). Obviously, this is a somewhat unrealistic
example because it includes the most severe state experienced by
respondents with the lowest income, but indicates that the
results should be interpreted with caution, because they may
indicate only relative values rather than absolute values. It is
possible that the values suffer from “hypothetical bias,” when
people state that they are willing to pay higher values than they
would actually be willing to pay when using their own money in a
laboratory or ﬁeld experiment [33]. This is an important limita-
tion of this type of study that is purely hypothetical.
One limitation of the study is that the patient sample is
relatively small given that the survey design included 12 blocks of
10 DCE questions, meaning approximately 29 to 34 respondents
answered each block of 10 questions. This may have impacted on
the signiﬁcance of coefﬁcients for the regression models esti-
mated on the patient samples.
The regression models had some insigniﬁcant and some
inconsistent results. It is, however, important to note that it is
not uncommon for valuation surveys of classiﬁcation systems to
ﬁnd this; for example, the UK valuation of the SF-6D using
standard gamble had both inconsistent and insigniﬁcant coefﬁ-
cients [4,5].
The design of the survey may have impacted on the results.
The DCE tasks ask respondents to consider two health descrip-
tions that contained 18 pieces of information (9 pieces per
description). This is a large amount of information to simulta-
neously consider and could mean that respondents did not fully
consider all information or all attributes. Other valuation surveys
of classiﬁcation systems have also included a large number of
attributes (e.g., the survey by Norman et al. [34] included 11
attributes), and yet in the design these have ﬁxed some attributes
at the same level across both proﬁles in the DCE, and this is an
option recommended for use in future surveys. It is possible that
there may be interaction in preferences for some of the attrib-
utes, for example, mood and stress. Nevertheless, the study
design selected choice sets assuming an additive model, meaning
that interaction effects cannot be accurately estimated.
The use of existing general population online panels can be
criticized for not being representative of the UK population.
Members of online panels may differ from the general population
in that they exclude the computer illiterate and those without
access to the Internet. In addition, respondents have signed up to
be members of a panel with a market research agency and stated
that they are willing to answer surveys in return for points that
can be exchanged for goods, and therefore their motivation for
undertaking the survey may have an impact on their responses,
potentially making their responses unrepresentative. Neverthe-
less, in terms of sociodemographic characteristics measured,
they were found to be similar to the UK general population
except that there being fewer who were older than 65 years and
in contrast a larger proportion of retired respondents, although
they may differ in terms of other unmeasured characteristics.
The patient sample was different in ways that would be expected
for those with diabetes.
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accuracy of the elicitation of preferences for the cost attribute.
The UK health care system is publicly funded, meaning that the
general population receives free health care at the point of use
with the exception of small charges such as prescription charges.
This means that respondents are not used to paying for health
care, or paying to improve their health state. This may have
affected the results because it may mean that responses are not
fully considered or fully informed because of inexperience in
paying for health care or health improvement. It is possible that
the selection of four levels rather than a higher number for the
cost attribute may have also affected the results. In addition,
respondents were forced to make a choice, meaning that they
could not state indifference or have an “opt out” response
indicating that they were not prepared to pay any cost for their
health. This may have affected the results, because this does not
reﬂect real life in which people can choose to not pay to improve
their health. From a modeling perspective, however, an indiffer-
ence or opt-out option is not beneﬁcial, although it would
indicate these respondents who may have chosen at random.
One possibility is to include a zero cost level, and further research
is encouraged to determine how this impacts on responses.
The DCE in this study was purposively designed to maximize
statistical efﬁciency and minimize any dominance, for example,
when one proﬁle is clearly dominant or dominant with the
exception of one attribute such as cost. Therefore, although we
can observe within choice sets whether the low or high cost
option was selected (where cost differs), we are unable to infer
whether this selection was only due to cost, mainly due to cost,
or despite cost. A better way to examine this question would be a
binary choice survey with speciﬁcally selected scenarios to
examine dominance of the cost attribute, a small think-aloud
survey asking respondents the reasons for their choices directly,
and/or research using eye tracking devices to determine where
respondents focus their gaze when making their choices. This is
an important issue for further research.
The wording of the cost attribute may have impacted on the
results. In the proﬁles the wording was “The monthly cost of
treatment to you.” It is possible that respondents may not have
correctly interpreted the cost as being applicable every month
and may have instead interpreted it as a one-off payment. The
frequency of payment as monthly rather than annually may have
also had an effect as, for example, altering the wording to annual
rather than monthly may not have multiplied the size of the WTP
estimates by 12 times.Conclusions
This article contributes to the methodological literature on the
valuation of standardized patient-reported outcome measures
using WTP for potential application in CBA. This approach could
potentially add to the use of WTP in economic evaluation. The
levels of the cost attribute used in the DCE survey were derived
empirically, adding strength to the approach. The project also
compared general population and diabetic patient values. Overall
this approach shows promise, but there are some concerns with
some inconsistencies in results, insigniﬁcant coefﬁcients, and
large WTP estimates observed that extend beyond the cost levels
used in the survey. The novel application of DCE with a cost
attribute to value a classiﬁcation system provides an alternative
approach to DCE with duration, an approach that has been
previously used to value classiﬁcation systems. Further research
applying DCE with a cost attribute to value a classiﬁcation system
and to compare this method with DCE with duration is ongoing.Acknowledgments
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